SEC Form 4 · accession 0001104659-19-002494
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonardus H.T. Van der Ploeg
Officer — Chief Scientific Officer
Period of report
Jan 16, 2019
Accepted (ET)
Jan 18, 2019 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 16, 2019 | S | 200 | $30.00 | D | 42,339 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 16, 2019, Mr. Van der Ploeg sold 200 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.